RAB22A and colorectal cancer: A previous study revealed that miR-211 suppresses epithelial ovarian cancer proliferation and cell-cycle progression by targeting Cyclin D1 and CDK6 (36), and miR-204-5p suppresses proliferation and invasion, and promotes chemotherapeutic sensitivity of colorectal cancer cells by downregulating RAB22A (37).